Federal health organizations recently introduced an additional booster vaccine for those at high risk of contracting COVID-19, as medical professionals keep a close watch on the Arcturus variant or XBB.1.16. Unlike previous strains of COVID-19, the Arcturus strain may cause conjunctivitis, an eye condition commonly associated with viral or bacterial infections, and allergies. According to Dr. William Schaffner, an infectious disease expert at Vanderbilt University Medical Center, this variant stands out in two ways: it causes fever, and conjunctivitis. Although viral and allergic conjunctivitis share similar symptoms, it is challenging to tell the difference between them and COVID-19-induced conjunctivitis, which requires assessment by an eye doctor using special dyes and equipment. While there is currently no scientific evidence linking conjunctivitis to Arcturus, anecdotal evidence from practitioners suggests it is probable. The World Health Organization has classified this currently low-risk strain as a “variant under monitoring.” Despite having unique symptoms, much of the classic symptoms of COVID-19, such as cough, loss of taste and smell, chills, and body aches, remain prevalent. Hygiene practices such as washing hands with soap and water, wearing masks, and keeping a safe distance from others are still crucial in curbing the spread of the virus. If you have conjunctivitis from allergies, you can treat symptoms with over-the-counter eye drops, allergy shots, or prescription medication from a medical professional.
